PRODUCT DEVELOPMENT

PRODUCT DEVELOPMENT

Infectious Diseases

Infectious Diseases


We are committed to developing advanced and accessible RNA vaccines for the prevention and treatment of infectious diseases. Our RNA vaccine technology offers potential advantages in safety, efficacy, development speed, and manufacturing scalability enabling us to better prepare for and respond to potential infectious disease outbreaks.

Tumor Immunotherapies

Tumor Immunotherapies


We apply our RNA technology to the emerging field of tumor immunotherapy, aiming to activate the human immunesystem to recognize and attack cancercells. Leveraging the programmability andtransient expression characteristics of RNA, our strategy avoids the risks of genomic integration while enabling rapid, tissue-specific, and innovative therapies.

Autoimmune Diseases

Autoimmune Diseases


Autoimmune diseases occur when the immune system malfunctions and mistakenly attacks it's own healthy tissues as if they were foreign threats. Depending on the scope of the attack, these diseases can be categorized into various types, ranging from localizeddamage to specific argans to systemic involvement affecting multiple body systems. We are developing potential mRNA-based therapies that we believe have the potential to help restore immune homeostasis.

Skin Health

Skin Health


We are actively expanding into theconsumer healthcare sector and have innovatively developed an mRNA therapeutic acne vaccine,aiming to serve patients with moderate.to severe acne who face challenges such as insufficient efficacy, drug resistance, or high recurrence rates.


Business license

Statement

SEO